sbynews

DelMarVa’s Premier Source for Conservative News, Opinion, Analysis, and Human Interest

Contact Publisher Joe Albero at alberobutzo@wmconnect.com or 410-430-5349

The opinions expressed by columnists are their own and do not represent our advertisers

Hyping the Next Plandemic: Researchers in Nebraska Develop “Vaccine” Targeting All Flu Strains

Scientists at the University of Nebraska-Lincoln (UNL) have developed a single vaccine that targets multiple strains of influenza – including swine flu, bird flu and seasonal flu – fueling concerns that the next plandemic is on the horizon.

The experimental vaccine, designed using advanced computational modeling, has shown promise in protecting pigs against diverse influenza A viruses. The researchers have also expressed optimism that the injection will protect birds and humans from these pathogens. But skeptics warn that such vaccines may carry unforeseen dangers, including immune suppression and failure against mutated strains.

In a study published late last month in Nature Communications, the UNL researchers detailed how the Epigraph vaccine – named after the software used to design it – outperformed existing commercial vaccines in swine trials. Pigs vaccinated with Epigraph developed robust immunity against 12 different flu strains – including the H1N1 virus responsible for the 2009 swine flu pandemic. The H1N1 strain infected a quarter of the global population and killed over half a million people.

Dr. Eric Weaver, the study’s lead author, called the findings a critical step toward a universal flu vaccine that could last a decade or longer. “If we can prevent influenza in swine, we can cut off the virus’s evolutionary advantage,” he added. According to Weaver, also the director of the Nebraska Center for Virology at UNL, pigs often act as a “mixing vessel” for dangerous zoonotic jumps between birds and humans.

Is the Epigraph flu injection a Trojan horse for the next plandemic?

The Epigraph vaccine was developed after researchers analyzed over 6,000 influenza strains from the past century to identify common viral markers (epitopes) that trigger immune responses. Unlike traditional vaccines, which target rapidly mutating surface proteins, targeting these epitopes could lead to broader, longer-lasting protection.

Weaver’s team is now testing a dual H1/H3 variant vaccine, with hopes of eventual human trials. However, no timeline has been set for public availability.

More

2 thoughts on “Hyping the Next Plandemic: Researchers in Nebraska Develop “Vaccine” Targeting All Flu Strains”

Leave a Comment

Your email address will not be published. Required fields are marked *